XML 41 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights

The following table sets forth the changes in the number of warrants outstanding for the periods presented, exclusive of the warrants issued to Rusnano in connection with their loan to Panacela as those warrants are not exercisable until an event of default which has not occurred:

 

     Number of
Warrants
    Weighted Average
Exercise Price
     Number of Common
Shares Exercisable Into
 

Outstanding at December 31, 2011

     10,121,219      $ 3.76         12,564,193   

Granted

     4,312,500        3.00         4,312,500   

Forfeited, Canceled

     (4,055,724 )      5.07         (6,498,698 ) 
  

 

 

      

 

 

 

Outstanding at December 31, 2012

     10,377,995        2.94         10,377,995   

Granted

     156,250        1.60         156,250   
  

 

 

      

 

 

 

Outstanding at December 31, 2013

     10,534,245        2.70         10,534,245   
  

 

 

      

 

 

Schedule of Share-Based Compensation Shares Authorized Under Warrants by Exercise Price Range

The following table sets forth the details of the outstanding warrants as of December 31, 2013:

 

Expiration Date

   Current
Exercise Price
     Number of
Warrants
 

March 2, 2015

   $ 1.60         935,385   

June 17, 2015

     5.00         176,175   

February 12, 2016

     1.60         929,826   

March 19, 2016

     1.60         1,921,795   

March 26, 2016

     1.60         634,189   

June 22, 2016

     5.00         1,468,125   

October 24, 2017

     3.00         4,312,500   

September 30, 2018

     1.60         156,250   
     

 

 

 
        10,534,245   
     

 

 

Schedule of Share-based Compensation, Stock Options Activity

The following is a summary of option award activity under the Plan for the year ended December 31, 2013:

 

     Year Ended December 31, 2013  
     Total Stock Options
Outstanding
    Weighted Average
Exercise Price per
Share
     Nonvested Stock
Options
    Weighted Average
Grant Date Fair
Value per Share
 

December 31, 2012

     5,016,916      $ 4.54         404,500      $ 2.30   

Granted

     903,775        1.67         903,775        1.21   

Vested

     —          —           (513,296 )      1.73   

Exercised

     (9,681 )      1.28         —          —     

Forfeited, Canceled

     (346,177 )      3.53         (200,500 )      1.21   
  

 

 

      

 

 

   

December 31, 2013

     5,564,833        4.14         594,479        1.50   
  

 

 

      

 

 

   
Schedule of Share-based Compensation, Activity

The following is a summary of outstanding stock options under the Plan as of December 31, 2013:

 

     Stock Options
Outstanding
     Vested Stock
Options
 

Quantity

     5,564,833         4,970,354   

Weighted-average exercise price

   $ 4.14       $ 4.40   

Weighted Average Remaining Contractual Term (in Years)

     6.75         6.47   

Intrinsic value

   $ 11,592       $ 11,592